In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Susana Banerjee, MBBS, MA, FRCP, PhD
Consultant Medical Oncologist
Research Lead Gynaecology Unit
The Royal Marsden NHS Foundation Trust
Professor in Women’s Cancers
Dr. Banerjee has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: AstraZeneca, GlaxoSmithKline Immunogen, Merck Sharpe Dohme, Mersana, Myriad, Oncxerna, Seagen, Takeda, Verastem
Contracted Research: AstraZeneca,GlaxoSmithKline, Verastem, Immunogen, MSD, Mersana, Seagen
Ownership Interest: Phenutest
Bradley McGregor, MD
Director, Clinical Research for the Lank Center of Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, MA
Dr. McGregor has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: BMS, Eisai, Exelixis, Gilead, Pfizer, Seagen
Contracted Research: BMS, Exelixis, Gilead, Pfizer, Seagen
Kathleen N. Moore, MD, MS
Co-Director, Cancer Therapeutics Program
Stephenson Cancer Center at the University of Oklahoma HSC
Oklahoma City, OK
Dr. Moore has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Aadi, Aravive, Astra Zeneca, Blueprint, Clovis, Caris, Duality, Eisai, Genentech/Roche, GSK, Immunogen, Janssen, Lilly, Merck, Mersana, Onconova, Pannavance, Regeneron, VBL, Verastem, ZEntalis
Contracted Research: Aravie, Astra Zeneca, Blueprint, Clovis, Duality, GSK, Genentech/Roche, Immunogen, Lilly, PTC Therapeutics, Regeneron, Verastem
Shubham Pant, MD, MBBS
Associate Professor
Department of Gastrointestinal Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Dr. Pant has reported no relevant disclosures at this time.
Reviewers/Content Planners/Authors: